Detail of "16039-52-4"

CAS Number:
16039-52-4
Name:
Copper, bis[2-(hydroxy-kO)propanoato-kO]-
Molecular Structure:
Formula:
C₆H₁₀CuO₆
Molecular Weight:
241.69
Synonyms:
Bis(2-(hydroxy-kappaO)propanoato-kappaO)copper;Copper dilactate;Copper lactate;Copper, bis(2-hydroxypropanoato-O1,O2)-;Propanoic acid, 2-hydroxy-, copper complex;HSDB 263;CID13145;Copper 2-hydroxypropanoate;
EINECS:
240-177-3
Boiling Point:
227.6 °C at 760 mmHg
Flash Point:
109.9 °C

Please post your buying leads,so that our qualified suppliers will soon contact you!
*Required Fields

New dextran derivatives: New dextran derivatives. II. Preparation of compounds of copper(II) with 3-mercapto-2-hydroxypropyl ether of dextran. Mioduszewski, Jan Z.; Mioduszewska, Mieczyslawa (Dep. Nat. Compd., Inst. Pharm. Ind., Warsaw 01-793, Pol.). Arch. Immunol. Ther. Exp., 31(5), 669-75 (English) 1983. CODEN: AITEAT. ISSN: 0004-069X. DOCUMENT TYPE: Journal CA Section: 63 (Pharmaceuticals) Section cross-reference(s): 1, 33 Hydrogenated 3-mercapto-2-hydroxypropyl dextran ether was prepd. from Na2S and hydrogenated 3-chloro-2-hydroxyproyl dextran ether, and the mercapto ether was mixed with a CuSO4 soln. under N and then with Na2S soln. to give the CuS complex. The dark-brown soln. was filtered, ultrafiltered, pptd. 62340-64-1 and 7758-98-7 are also in the experiment. with Me2CO twice, and dried under reduced pressure. The complex contained 2.25% Cu; fractions with the highest mol. wt. contained the most Cu, up to 5%. If cupric lactate [16039-52-4] were used instead of CuSO4 it was possible to purify the product by EtOH pptn. instead of ultrafiltration. The powder was easily sol. in H2O or saline, and 15-20% solns. in ampuls contg. N could be sterilized at 115°. The compd. had antianemic activity (synergism with iron dextran) and immunotropic activity. .

Calcium and trace mineral supplements for treatment of age-related bone loss: Calcium and trace mineral supplements for treatment of age-related bone loss. Saltman, Paul David; Smith, Kenneth Thomas (Procter and Gamble Co.; University of California, Oakland, USA). PCT Int. Appl. WO 9202235 A1 20 Feb 1992, 30 pp. DESIGNATED STATES: W: AU, CA, FI, JP, KR; RW: AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, NL, SE. (World Intellectual Property Organization). CODEN: PIXXD2. CLASS: ICM: A61K033-34. ICS: A61K033-24. ICI: A61K033-34, A61K033-24, A61K033-32, A61K033-30, A61K031-19. APPLICATION: WO 91-US5496 2 Aug 1991. PRIORITY: US 90-562773 6 Aug 1990. DOCUMENT TYPE: Patent CA Section: 18 (Animal Nutrition) A method for building in bone in humans suffering from age-related bone loss using a mineral supplement of Ca citrate malate and Zn, Mn, and Cu salts for a period of time, preferably 36 mo. is described. 7440-66-6 and 16039-52-4 are also in the experiment. Ca citrate malate is administered at 175-2000 mg/day (on elemental Ca basis), the Zn at 1.5-30, the Mn at 1-8, and the Cu at 1.0-5.0 mg/day. Post-menopausal women provided this mineral supplement showed a net bone building effect of 2.24% compared to a placebo group. .